Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × HhAntag691 × Clear all

NCT01071564 2015-04-15

RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery

Phase 1 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms